Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$1.27 - $8.28 $2.59 Million - $16.9 Million
-2,036,495 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$7.04 - $10.49 $95,786 - $142,726
13,606 Added 0.67%
2,036,495 $16.5 Million
Q2 2021

Aug 12, 2021

BUY
$6.08 - $10.44 $6.75 Million - $11.6 Million
1,110,290 Added 121.66%
2,022,889 $19.9 Million
Q1 2021

May 13, 2021

BUY
$8.35 - $12.39 $7.62 Million - $11.3 Million
912,599 New
912,599 $8.05 Million

Others Institutions Holding GRTX

About Galera Therapeutics, Inc.


  • Ticker GRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,821,600
  • Market Cap $1.07M
  • Description
  • Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...
More about GRTX
Track This Portfolio

Track Aigh Capital Management LLC Portfolio

Follow Aigh Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aigh Capital Management LLC with notifications on news.